Polyphenols mitigating inflammatory mechanisms in Inflammatory Bowel Disease (IBD): focus on NF-κB and JAK/STAT pathways

The term "inflammatory bowel disease" (IBD) refers to a group of chronic inflammatory gastrointestinal disorders, which include ulcerative colitis and Crohn's disease. The necessity for alternative therapeutic approaches is underscored by the fact that, although present medicines are...

Full description

Bibliographic Details
Main Authors: Ismail, Elysha Nur, Vidyadaran, Sharmili, Othman, Zulkefley, Muhamad Zakuan, Noraina, Ishak, Reezal, Mohammad, Hussin
Format: Article
Language:English
Published: Springer 2024
Online Access:http://psasir.upm.edu.my/id/eprint/120197/
http://psasir.upm.edu.my/id/eprint/120197/1/120197.pdf
_version_ 1848868136140406784
author Ismail, Elysha Nur
Vidyadaran, Sharmili
Othman, Zulkefley
Muhamad Zakuan, Noraina
Ishak, Reezal
Mohammad, Hussin
author_facet Ismail, Elysha Nur
Vidyadaran, Sharmili
Othman, Zulkefley
Muhamad Zakuan, Noraina
Ishak, Reezal
Mohammad, Hussin
author_sort Ismail, Elysha Nur
building UPM Institutional Repository
collection Online Access
description The term "inflammatory bowel disease" (IBD) refers to a group of chronic inflammatory gastrointestinal disorders, which include ulcerative colitis and Crohn's disease. The necessity for alternative therapeutic approaches is underscored by the fact that, although present medicines are successful, they frequently result in considerable adverse effects. Naturally occurring substances included in fruits and vegetables called polyphenols have been shown to have the capacity to control important inflammatory pathways including NF-κB and JAK/STAT, which are essential to the pathophysiology of IBD. The processes by which polyphenols, such as curcumin, EGCG, resveratrol, and quercetin, reduce inflammation are examined in this article. Polyphenols may have therapeutic advantages by blocking the synthesis of cytokines and the activation of immune cells by targeting these pathways. Preclinical study indicates a reduction in intestinal inflammation, which is encouraging. However, more clinical research is needed to determine the clinical relevance of polyphenols in the therapy of IBD, especially with regard to their long-term safety and bioavailability
first_indexed 2025-11-15T14:47:35Z
format Article
id upm-120197
institution Universiti Putra Malaysia
institution_category Local University
language English
last_indexed 2025-11-15T14:47:35Z
publishDate 2024
publisher Springer
recordtype eprints
repository_type Digital Repository
spelling upm-1201972025-09-25T02:11:49Z http://psasir.upm.edu.my/id/eprint/120197/ Polyphenols mitigating inflammatory mechanisms in Inflammatory Bowel Disease (IBD): focus on NF-κB and JAK/STAT pathways Ismail, Elysha Nur Vidyadaran, Sharmili Othman, Zulkefley Muhamad Zakuan, Noraina Ishak, Reezal Mohammad, Hussin The term "inflammatory bowel disease" (IBD) refers to a group of chronic inflammatory gastrointestinal disorders, which include ulcerative colitis and Crohn's disease. The necessity for alternative therapeutic approaches is underscored by the fact that, although present medicines are successful, they frequently result in considerable adverse effects. Naturally occurring substances included in fruits and vegetables called polyphenols have been shown to have the capacity to control important inflammatory pathways including NF-κB and JAK/STAT, which are essential to the pathophysiology of IBD. The processes by which polyphenols, such as curcumin, EGCG, resveratrol, and quercetin, reduce inflammation are examined in this article. Polyphenols may have therapeutic advantages by blocking the synthesis of cytokines and the activation of immune cells by targeting these pathways. Preclinical study indicates a reduction in intestinal inflammation, which is encouraging. However, more clinical research is needed to determine the clinical relevance of polyphenols in the therapy of IBD, especially with regard to their long-term safety and bioavailability Springer 2024-12-05 Article PeerReviewed text en cc_by_nc_nd_4 http://psasir.upm.edu.my/id/eprint/120197/1/120197.pdf Ismail, Elysha Nur and Vidyadaran, Sharmili and Othman, Zulkefley and Muhamad Zakuan, Noraina and Ishak, Reezal and Mohammad, Hussin (2024) Polyphenols mitigating inflammatory mechanisms in Inflammatory Bowel Disease (IBD): focus on NF-κB and JAK/STAT pathways. Inflammopharmacology, 33. pp. 759-765. ISSN 0925-4692; eISSN: 1568-5608 https://link.springer.com/article/10.1007/s10787-024-01607-8#citeas 10.1007/s10787-024-01607-8
spellingShingle Ismail, Elysha Nur
Vidyadaran, Sharmili
Othman, Zulkefley
Muhamad Zakuan, Noraina
Ishak, Reezal
Mohammad, Hussin
Polyphenols mitigating inflammatory mechanisms in Inflammatory Bowel Disease (IBD): focus on NF-κB and JAK/STAT pathways
title Polyphenols mitigating inflammatory mechanisms in Inflammatory Bowel Disease (IBD): focus on NF-κB and JAK/STAT pathways
title_full Polyphenols mitigating inflammatory mechanisms in Inflammatory Bowel Disease (IBD): focus on NF-κB and JAK/STAT pathways
title_fullStr Polyphenols mitigating inflammatory mechanisms in Inflammatory Bowel Disease (IBD): focus on NF-κB and JAK/STAT pathways
title_full_unstemmed Polyphenols mitigating inflammatory mechanisms in Inflammatory Bowel Disease (IBD): focus on NF-κB and JAK/STAT pathways
title_short Polyphenols mitigating inflammatory mechanisms in Inflammatory Bowel Disease (IBD): focus on NF-κB and JAK/STAT pathways
title_sort polyphenols mitigating inflammatory mechanisms in inflammatory bowel disease (ibd): focus on nf-κb and jak/stat pathways
url http://psasir.upm.edu.my/id/eprint/120197/
http://psasir.upm.edu.my/id/eprint/120197/
http://psasir.upm.edu.my/id/eprint/120197/
http://psasir.upm.edu.my/id/eprint/120197/1/120197.pdf